Neoplasia Flashcards
differentiate between the definitions tumour, neoplasm and oncology.
- tumour : any clinically detectable lump or swelling.
- neoplasm : abnormal growth of cells that persists after initial stimulus removed.
- oncology : study of tumours and neoplasms.
what is the difference between a benign neoplasm and malignant neoplasm?
- benign : gross and microscopic appearances that will remain localised, not spreading to other sites.
- pushes outer margins, closely resembles parent tissue.
- malignant : abnormal growth that persists after initial stimulus removed and invades surrounding tissue with potential to spread distally.
- may have ulcerations and necrosis, poorly differentiated mostly.
define metastasis.
- malignant neoplasm that has spread from its original site to new non-contagious site.
what is dysplasia?
what is anaplastic?
- pre-neoplastic alteration in which cells show disordered tissue organisation, reversible, pleomorphism seen, large hyper-chromatic nuclei and high nuclear:cytoplasmic ratio.
- cells with no resemblance to any tissue.
how is neoplasia graded? what is taken into account?
- DIFFERENTIATION : higher grades indicate poor differentiation.
why do we get neoplasia?
- carcinogenesis.
- genetic damage.
- accumulation of mutations.
- mutations caused by initiators and proliferation caused by promoters.
give some examples of initiators.
- chemicals : smoking, alcohol, diet and obesity.
- infectious agents : HPV.
- radiation.
- inherited mutations.
which genes being affected increases risk of neoplasia?
- growth promoting proto-oncogenes.
- growth inhibiting tumour suppressor genes.
- genes that regulate apoptosis.
- genes involved in DNA repair.
what is the significance with proto-oncogene mutations?
- participates in signalling pathways that drive proliferation.
- ‘gain of function’ mutations and mutations in encode proteins called oncoproteins promote cell growth.
what are tumour suppressor genes?
- stops cell proliferation, usually subject to ‘loss of function’ mutations.
- both alleles damaged for transformation to occur.
eg: TP53.
what about apoptosis regulating genes and DNA repair genes?
- apoptosis ; less cell death and enhanced survival.
- DNA repair : ‘loss of function’ mutation, impairs ability to recognise and repair non-lethal genetic damage, accumulation of mutations.
how would you generally name neoplasms?
- benign -oma.
- malignant : carcinoma if epithelial, sarcoma in stromal.
CHECK SLIDEZ.
define invasion in terms of metastatic neoplasia.
- breach of basement membrane with progressive infiltration and destruction of surrounding tissue.
describe the journey of metastases.
- grow, invade at primary site.
- enter transport system and lodge at secondary site.
- grow at secondary site to from new tumour.
what are the 3 key events of carcinoma invasion?
- adhesion : reduction in E-cadherin expression to more motile, changes in integrin expression.
- stromal proteolysis : altered expression of enzymes, degrades basement membrane and stroma to allow invasion. surrounding tissue provide growth factors and proteases.
- motility : changes to actin cytoskeleton.
how does it spread to distant sites?
- blood vessels, lymphatics, body cavity fluids.
what is the significance of micrometaastases?
- failed colonisation deposits wait for optimum conditions such as immunosuppression to proliferate and invade.
what determines site of secondary tumour?
- regional damage of blood, lymph etc.
- lymphatic metastases drain to lymph nodes.
- breast cancer ipsilateral axillary lymph nodes.
- blood-borne : next capillary bed.
common neoplasms that spread to bone can be detected on plain films. what are some examples.
- breast, bronchus, kidney, thryroid, prostate.
- osteolytic lesions due to destruction of bone.
what is meant by personalities of neoplasms.
- malignant more aggressive metastasises very early on.
- small cell carcinoma of bronchus v.aggressive.
- basal cell carcinoma on the other hand, almost never metastasises.
how does the hosts defence respond to neoplasia?
- tumour antigens recognised by CD8+ cytotoxic cells.
- immunocompromised increased risk.
- however might be missed by CD8+ as loss of or reduced antigen presentation, expression of immuno-suppressions.